Novel therapeutic approach to slow down the inflammatory cascade in acute/subacute spinal cord injury: Early immune therapy with lipopolysaccharide enhanced neuroprotective effect of combinational therapy of granulocyte colony-stimulating factor and bone-marrow mesenchymal stem cell in spinal cord injury
Bone-marrow mesenchymal stem cells (BM-MSCs) have not yet proven any significant therapeutic efficacy in spinal cord injury (SCI) clinical trials, due to the hostile microenvironment of the injured spinal cord at the acute phase. This study aims to modulate the inflammatory milieu by lipopolysacchar...
Main Authors: | Shiva Hashemizadeh, Saereh Hosseindoost, Ameneh Omidi, Hossein Aminianfar, Somayeh Ebrahimi-Barough, Jafar Ai, Babak Arjmand, Mahmoudreza Hadjighassem |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2022.993019/full |
Similar Items
-
Long-term administration of bumetanide improve functional recovery after spinal cord injury in rats
by: Shiva Hashemizadeh, et al.
Published: (2022-10-01) -
β2-Adrenergic receptor agonist enhances the bystander effect of HSV-TK/GCV gene therapy in glioblastoma multiforme via upregulation of connexin 43 expression
by: Saereh Hosseindoost, et al.
Published: (2022-09-01) -
Case Report: Combination Therapy with Mesenchymal Stem Cells and Granulocyte-Colony Stimulating Factor in a Case of Spinal Cord Injury
by: Nazi Derakhshanrad, et al.
Published: (2015-10-01) -
Therapy of an incomplete spinal cord injury by intrathecal injection of EPO and subcutaneous injection of EPO, vitamin C and G-CSF
by: Bader A, et al.
Published: (2017-11-01) -
Early CSF Biomarkers and Late Functional Outcomes in Spinal Cord Injury. A Pilot Study
by: Rita Capirossi, et al.
Published: (2020-11-01)